ResMed ROA 2006-2018 | RMD

Current and historical return on assets (ROA) values for ResMed (RMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ResMed ROA for the three months ending September 30, 2018 was 15.99%.
ResMed ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.34B $3.07B 10.16%
2018-06-30 $0.32B $3.06B 9.26%
2018-03-31 $0.31B $3.53B 8.76%
2017-12-31 $0.29B $3.56B 8.20%
2017-09-30 $0.35B $3.49B 10.30%
2017-06-30 $0.34B $3.47B 10.14%
2017-03-31 $0.32B $3.42B 9.73%
2016-12-31 $0.33B $3.32B 10.59%
2016-09-30 $0.35B $3.32B 12.29%
2016-06-30 $0.35B $3.26B 13.85%
2016-03-31 $0.36B $2.45B 15.66%
2015-12-31 $0.36B $2.24B 15.95%
2015-09-30 $0.35B $2.26B 15.57%
2015-06-30 $0.35B $2.18B 15.48%
2015-03-31 $0.35B $2.28B 15.22%
2014-12-31 $0.35B $2.33B 15.04%
2014-09-30 $0.35B $2.31B 14.84%
2014-06-30 $0.35B $2.36B 14.71%
2014-03-31 $0.33B $2.37B 14.30%
2013-12-31 $0.33B $2.35B 14.07%
2013-09-30 $0.32B $2.34B 13.71%
2013-06-30 $0.31B $2.21B 13.40%
2013-03-31 $0.31B $2.38B 13.69%
2012-12-31 $0.29B $2.33B 13.16%
2012-09-30 $0.28B $2.25B 12.91%
2012-06-30 $0.26B $2.14B 12.42%
2012-03-31 $0.24B $2.13B 11.60%
2011-12-31 $0.23B $2.04B 11.24%
2011-09-30 $0.22B $1.94B 11.21%
2011-06-30 $0.23B $2.07B 11.73%
2011-03-31 $0.22B $1.96B 12.17%
2010-12-31 $0.22B $1.88B 12.37%
2010-09-30 $0.21B $1.79B 12.14%
2010-06-30 $0.19B $1.63B 11.55%
2010-03-31 $0.18B $1.71B 11.27%
2009-12-31 $0.17B $1.62B 11.33%
2009-09-30 $0.16B $1.62B 11.11%
2009-06-30 $0.15B $1.51B 10.75%
2009-03-31 $0.13B $1.33B 9.83%
2008-12-31 $0.12B $1.31B 9.08%
2008-09-30 $0.12B $1.29B 8.54%
2008-06-30 $0.11B $1.41B 8.25%
2008-03-31 $0.11B $1.37B 8.34%
2007-12-31 $0.06B $1.32B 5.07%
2007-09-30 $0.07B $1.29B 5.43%
2007-06-30 $0.07B $1.25B 5.82%
2007-03-31 $0.06B $1.19B 5.68%
2006-12-31 $0.10B $1.13B 10.11%
2006-09-30 $0.10B $1.03B 10.10%
2006-06-30 $0.09B $1.01B 9.70%
2006-03-31 $0.08B $0.90B 9.56%
2005-12-31 $0.07B $0.86B 9.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.846B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00